I'm not a fan of downrampers but I don't think ignoring haters is wise approach to investing. Always good to hear the other side of an argument to perhaps find blind spots in how you value and risk measure an opportunity, especially in the speculative side of town.
Saying that, the whole point of forums like HC is to share in our research and observations, and generally it's best to back any claims up with legitimate documents or links to articles/industry-related data, ideally from the company itself or a reputed entity, rather than be driven by sentiment or 'gut feel' or bitter regret for losses of yesteryear.
My dream is for MNS to pop 20x next year so I can early retire, but the data and research I've done has helped me calibrate a more realistic 3-5x in the near term. Still worth holding but not worth quitting my job on this play
- Forums
- ASX - By Stock
- MNS
- iM3NY Valuation
iM3NY Valuation, page-103
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online